J&J, ImmunityBio and Foghorn Therapeutics stand out as oncology players amid rapid innovation in cancer care with advancing pipelines, approvals and partnerships.
Precision medicine has revolutionized the landscape of neurological care, shifting from “one-size-fits-all” approaches to ...
The global market for Gastrointestinal Diagnostics was valued at US$4.9 Billion in 2024 and is projected to reach US$5.8 Billion by 2030, growing at a CAGR of 2.8% from 2024 to 2030. This ...
While the potential benefits of AI in obesity prevention are substantial, the study devotes significant attention to ...
A Scientific Reports study developed a pattern neural network that integrates total antioxidant status with clinical and ...
Today at the San Antonio Breast Cancer Symposium (SABCS), researchers presented the initial findings from a major multi-year ...
Platelet-to-Lymphocyte Ratio (PLR): Elevated PLR is another key marker linked to more aggressive tumor characteristics, such ...
Parkinson's disease represents a $6-8 billion market today, projected to exceed $13 billion by the 2030s, driven by rising ...
Pakistan: Researchers have found in a new study that machine learning models show strong promise in predicting postoperative ...
IRVING, Texas, Dec. 4, 2025 /PRNewswire/ -- Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced that the ...
Introduction Most neurological outpatient care (NOPC) in the UK is delivered without mandated clinical coding, with fewer than 20% of clinicians participating. As a result, data on NOPC in the UK is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results